Surgery for Cerebral Stroke
Online ISSN : 1880-4683
Print ISSN : 0914-5508
ISSN-L : 0914-5508
Review Articles
Perioperative Management of Severe Subarachnoid Hemorrhage
Tsuyoshi OHTAMasaomi KOYANAGIMasanori GOTORyu FUKUMITSUTadashi SUNOHARANobuyuki FUKUIMasaki TAKAHARATomomi ISHIKAWAMayuko MIYATAShinji KAJIURAYasuhiro YAMAMOTOKazuhiro KASASHIMAKenta YAMAMOTOMikako NOMOTOTakateru TAKAMATSUMasanori TOKUDAHikari TOMITAMai YOSHIMOTOTakenori OHGAKenta KOUNUSHIKosei JINZENJI
Author information
JOURNAL FREE ACCESS

2025 Volume 53 Issue 6 Pages 363-368

Details
Abstract

In cases of ruptured cerebral aneurysmal subarachnoid hemorrhage, effective perioperative management is crucial before and after addressing the source of bleeding. Preoperative strategies aimed at reducing the risk of rebleeding include the use of intravenous anesthesia and a moderate reduction in blood pressure. However, the effectiveness of other management approaches, such as administering antifibrinolytic agents, conducting platelet transfusions during antiplatelet therapy, reversing anticoagulants, and applying ventricular drainage, remains unclear.

Postoperative care primarily focuses on the prevention and treatment of cerebral vasospasms. The differences in the effectiveness of clazosentan observed in domestic versus international trials may stem from variations in the dosage or application of combination therapies. Lumbar drainage may decrease the risk of secondary infarction at the time of discharge and improve neurological outcomes at six months.

Other postoperative strategies, such as liberal transfusion practices and the use of prophylactic anti-convulsants, have not been shown to improve outcomes. Conditions such as hyponatremia and meningitis may worsen vasospasms. Additionally, It is important to approach treatment withdrawal during the acute phase with caution, as some patients with severe conditions can still achieve independence due to the ambiguity in predicting their prognosis.

Furthermore, with Japan’s aging population, there are increasing concerns about the economic feasibility of ongoing therapy in the future.

Content from these authors
© 2025 by The Japanese Society on Surgery for Cerebral Stroke
Next article
feedback
Top